Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: January 27, 2023

Sagent Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for SAGENT PHARMS, and what generic and branded alternatives to SAGENT PHARMS drugs are available?

SAGENT PHARMS has seventy-five approved drugs.

There is one tentative approval on SAGENT PHARMS drugs.

Summary for Sagent Pharms

US Patents:	0
Tradenames:	59
Ingredients:	57
NDAs:	75

Drugs and US Patents for Sagent Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sagent Pharms	VANCOMYCIN HYDROCHLORIDE	vancomycin hydrochloride	INJECTABLE;INJECTION	200837-001	Aug 10, 2012	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Sagent Pharms Inc	FLUOROURACIL	fluorouracil	INJECTABLE;INJECTION	203609-001	Feb 17, 2016	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Sagent Pharms Inc	VECURONIUM BROMIDE	vecuronium bromide	INJECTABLE;INJECTION	078274-002	Dec 29, 2008	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Sagent Pharms Inc	PHENYLEPHRINE HYDROCHLORIDE	phenylephrine hydrochloride	SOLUTION;INTRAVENOUS	209967-003	Jan 16, 2020	AP1	RX	No	No		See Plans and Pricing				See Plans and Pricing
Sagent Pharms Inc	ZOLEDRONIC ACID	zoledronic acid	INJECTABLE;INTRAVENOUS	091493-001	Nov 24, 2014	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Sagent Pharms Inc	DESMOPRESSIN ACETATE	desmopressin acetate	INJECTABLE;INJECTION	204695-001	Aug 22, 2017	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
Sagent Pharms Inc	AMPICILLIN SODIUM	ampicillin sodium	INJECTABLE;INJECTION	090583-004	Nov 27, 2015	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon

Merck

Harvard Business School

Boehringer Ingelheim

AstraZeneca

McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.